Swiss Chems review: catalogue, lab reports, shipping (2026)
What Swiss Chems publishes about its catalogue, its lab reports, its shipping and its payment terms, read from swisschems.is on September 16, 2026and checked against FDA's warning letter database. A listing is not an endorsement, and we do not verify purity, identity or what is in any individual vial.
This page reports what published studies found. It is not medical advice, no provider-patient relationship is created by reading it, and nothing here is a recommendation to use any compound. Talk with a licensed clinician about your own situation. Read the full disclaimer.
At a glance
| Status | Open |
|---|---|
| Lab reports | Published on the site Lab reports are published where a reader can open them. Match the lot number on the vial to the report. |
| Ships to | United States, International |
| Payment | The site's own navigation groups payment into cards, wallets and crypto, and it publishes a Zelle walkthrough: the buyer picks the QR option at checkout, sends to a one-time Zelle ID, and emails a screenshot of the payment to support. A new Zelle ID is issued per order. |
| FDA warning letters | |
| Website | swisschems.is |
Sponsored links below; we may earn a commission. Details.
Visit Swiss ChemsPlain link. We are not an affiliate of Swiss Chems at this time.
Compounds listed
Products this vendor lists that match a compound we track, read from its own catalogue. Coded or abbreviated product names are not mapped, because that would mean guessing at what is in the vial.
- Sermorelin
- BPC-157
- Tesamorelin
- NAD+
- GHK-Cu
- KPV
- CJC-1295
- Ipamorelin
- Selank
- Semax
- Wolverine (BPC-157 + TB-500)
- MOTS-c
- PT-141
- 5-Amino-1MQ
- DSIP
- TB-500
- Epitalon
- Melanotan II
- Thymosin alpha-1
- LL-37
- Kisspeptin
What we found
Swiss Chems is the one vendor in this section we could confirm has received an FDA warning letter. FDA issued it on 10 December 2024 under MARCS-CMS 695663, addressed to Swisschems at a New York mailing address. The letter states that FDA reviewed the website at swisschems.is in October 2024 and observed that it offered semaglutide and retatrutide products for sale in the United States, and that it also reviewed the company's Facebook and Instagram pages.
Neither semaglutide nor retatrutide appeared in the product sitemap we read on 2026-09-16. The catalogue that remains runs to 135 items across peptides, SARMs, nootropics and powders, and covers a large share of the compounds tracked here. An Independent Test Results section in the main navigation holds searchable lab reports filterable by product and category.
Published terms are free shipping on United States orders over $100 and international orders over $300, with same-day United States dispatch advertised. Payment is split across cards, wallets, crypto and a manual Zelle flow. A warning letter is a public enforcement action, not a verdict; FDA publishes close-out letters separately when a firm resolves one, and none was linked from this letter's page.
What “research use only” means, and the market it sits in
Every vendor in this section sells material labelled for research, laboratory or analytical use and not for human consumption. That label is not a formality and it is not a loophole. It is the seller stating that the product has not been through the approval or compounding systems that govern medicines, and that it is not intended for a person.
The market is under active enforcement. FDA's public warning letter database shows a continuing run of unapproved-new-drug and misbranding letters to peptide sellers: Gram Peptides and Pink Pony Peptides on 31 March 2026, Wholesale Peptide on 17 June 2026, and five on a single day, 24 August 2026, to Peak Performance Peptides, Royal Peptides, NuScience Peptides, Peptide Partners and Tex Peptides. Of the vendors profiled here, one appears in that database: Swiss Chems, letter dated 10 December 2024.
Criminal exposure is real as well. In the Northern District of Indiana, the operators of Paradigm Peptides entered guilty pleas on 10 December 2025 over products sold as SARMs that in fact contained testosterone and over unapproved peptide and hCG products; both were sentenced in July 2026. Separately, payment processors have been withdrawing from this category, which is why so many storefronts route buyers to crypto, Zelle or bank wire rather than a card.
There is a lawful route for several of these compounds, and it is not this one. At its meeting on 23–24 July 2026, FDA's Pharmacy Compounding Advisory Committee voted to recommend BPC-157, KPV and TB-500 (8–6, one abstention) and MOTS-c (7–5, two abstentions) for the section 503A bulk drug substances list. That vote is advisory: FDA decides, and where compounding proceeds it runs through a licensed prescriber and a licensed pharmacy, not a research storefront.
Sources for this section
- FDA warning letter database (searched 16 September 2026)
- FDA warning letter to Swisschems, 10 December 2024 (MARCS-CMS 695663)
- FDA warning letter to Gram Peptides, 31 March 2026
- FDA warning letter to Peak Performance Peptides, 24 August 2026
- United States v. Matthew Kawa, N.D. Indiana (guilty pleas entered 10 December 2025)
- FDA Pharmacy Compounding Advisory Committee, 2026 meeting materials (meeting of 23–24 July 2026)
Compound profiles carry the regulatory status for each substance, and online peptide therapy covers the prescription route.
Frequently asked questions
Is Swiss Chems legit?
The storefront is live and has been trading for years, and it publishes lab reports and shipping terms. It also holds an FDA warning letter dated 10 December 2024 over semaglutide and retatrutide offered for sale in the United States, which is the single most concrete public fact about any vendor on this page. Read the letter itself before drawing a conclusion.
What did the FDA warning letter to Swiss Chems say?
FDA wrote that it reviewed swisschems.is in October 2024 and observed semaglutide and retatrutide products offered for sale in the United States, and that it had also reviewed the company's Facebook and Instagram pages. The letter is filed under MARCS-CMS 695663 and is linked from the facts table above.
What do Swiss Chems reviews say?
We do not aggregate customer reviews. The verifiable record is the warning letter, the current catalogue, the published lab-report library and the shipping and payment terms, all read or searched on 2026-09-16.
Does Swiss Chems have a discount code?
The site runs its own promotions and a rewards and referral programme rather than a standing public code, and it advertises free shipping over $100 in the United States. We do not issue codes for any vendor.
Does Swiss Chems publish certificates of analysis?
Yes. An Independent Test Results section in the navigation holds lab reports that can be searched by product and filtered by category, with an invitation to email support about a specific report.
How does paying by Zelle work there?
The published walkthrough is: choose the QR option at checkout, send the amount to the one-time Zelle ID shown, then email a screenshot of the payment to support. The site states a new Zelle ID is issued for every order and that an expired link means placing the order again.
Want it prescribed instead?
Nothing on this page is a route to a peptide for a person. The lawful route runs through a licensed prescriber and a licensed pharmacy, and for several of these compounds it exists today. Our telehealth section compares programs on prescriber type, pharmacy model, whether labs are required, state coverage and published pricing, and each compound profile states what can lawfully be prescribed or compounded right now.
Where the research stands
Our research digests summarise new studies against their primary sources, and are peptides legal explains the difference between an approved drug, a compounded preparation and a research chemical.